2024 CFR > Title 21 > Chapter I > Subchapter D > Part 312 > Subpart I – Expanded Access to Investigational Drugs for Treatment Use

2023 CFR > Title 21 > CHAPTER I > SUBCHAPTER D > PART 312 > Subpart I – Expanded Access to Investigational Drugs for Treatment Use

2022 CFR > Title 21 > Chapter I > Subchapter D > Part 312 > Subpart I – Expanded Access to Investigational Drugs for Treatment Use

2021 CFR > Title 21 > Chapter I > Subchapter D > Part 312 > Subpart I – Expanded Access to Investigational Drugs for Treatment Use

2020 CFR > Title 21 > Chapter I > Subchapter D > Part 312 > Subpart I – Expanded Access to Investigational Drugs for Treatment Use

2019 CFR > Title 21 > Chapter I > Subchapter D > Part 312 > Subpart I – Expanded Access to Investigational Drugs for Treatment Use

2016 CFR > Title 21 > Chapter I > Subchapter D > Part 312 > Subpart I – Expanded Access to Investigational Drugs for Treatment Use

2015 CFR > Title 21 > Chapter I > Subchapter D > Part 312 > Subpart I – Expanded Access to Investigational Drugs for Treatment Use

2014 CFR > Title 21 > Chapter I > Subchapter D > Part 312 > Subpart I – Expanded Access to Investigational Drugs for Treatment Use